Tags

Type your tag names separated by a space and hit enter

Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
Br J Dermatol. 2007 Nov; 157(5):1032-6.BJ

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL) observed mainly in Sudan and India where it follows treated VL in 50% and 10% of cases, respectively. We report a 46-year-old patient with acquired immune deficiency syndrome who, 7 months after diagnosis of VL, developed PKDL and uveal leishmaniasis following HAART-induced immune recovery. In southern Europe PKDL seems to be an emerging clinical presentation among human immunodeficiency virus (HIV)-infected patients experiencing HAART-induced immune recovery after a previous diagnosis of VL. The best treatment among HIV-infected patients remains to be determined.

Authors+Show Affiliations

Department of Clinical Sciences L Sacco, Infectious and Tropical Diseases Section, University of Milano, Via GB Grassi, 74, 20157 Milano, Italy. spinello.antinori@unimi.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

17854365

Citation

Antinori, S, et al. "Post-kala-azar Dermal Leishmaniasis as an Immune Reconstitution Inflammatory Syndrome in a Patient With Acquired Immune Deficiency Syndrome." The British Journal of Dermatology, vol. 157, no. 5, 2007, pp. 1032-6.
Antinori S, Longhi E, Bestetti G, et al. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. Br J Dermatol. 2007;157(5):1032-6.
Antinori, S., Longhi, E., Bestetti, G., Piolini, R., Acquaviva, V., Foschi, A., Trovati, S., Parravicini, C., Corbellino, M., & Meroni, L. (2007). Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. The British Journal of Dermatology, 157(5), 1032-6.
Antinori S, et al. Post-kala-azar Dermal Leishmaniasis as an Immune Reconstitution Inflammatory Syndrome in a Patient With Acquired Immune Deficiency Syndrome. Br J Dermatol. 2007;157(5):1032-6. PubMed PMID: 17854365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. AU - Antinori,S, AU - Longhi,E, AU - Bestetti,G, AU - Piolini,R, AU - Acquaviva,V, AU - Foschi,A, AU - Trovati,S, AU - Parravicini,C, AU - Corbellino,M, AU - Meroni,L, Y1 - 2007/09/13/ PY - 2007/9/15/pubmed PY - 2008/4/9/medline PY - 2007/9/15/entrez SP - 1032 EP - 6 JF - The British journal of dermatology JO - Br J Dermatol VL - 157 IS - 5 N2 - Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL) observed mainly in Sudan and India where it follows treated VL in 50% and 10% of cases, respectively. We report a 46-year-old patient with acquired immune deficiency syndrome who, 7 months after diagnosis of VL, developed PKDL and uveal leishmaniasis following HAART-induced immune recovery. In southern Europe PKDL seems to be an emerging clinical presentation among human immunodeficiency virus (HIV)-infected patients experiencing HAART-induced immune recovery after a previous diagnosis of VL. The best treatment among HIV-infected patients remains to be determined. SN - 0007-0963 UR - https://www.unboundmedicine.com/medline/citation/17854365/Post_kala_azar_dermal_leishmaniasis_as_an_immune_reconstitution_inflammatory_syndrome_in_a_patient_with_acquired_immune_deficiency_syndrome_ DB - PRIME DP - Unbound Medicine ER -